|
Somatostatin, also known as growth hormone–inhibiting hormone (GHIH) or by several other names, is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones. Somatostatin inhibits insulin and glucagon secretion. Somatostatin has two active forms produced by alternative cleavage of a single preproprotein: one of 14 amino acids (shown in infobox to right), the other of 28 amino acids which is the short form with another 14 amino acids at one end.〔(somatostatin preproprotein [Homo sapiens] See Features )〕 Among the vertebrates, there exist six different somatostatin genes that have been named SS1, SS2, SS3, SS4, SS5, and SS6. Zebrafish have all 6.〔 The six different genes along with the five different somatostatin receptors allows somatostatin to possess a large range of functions. Humans have only one somatostatin gene, SST. ==Nomenclature== Synonyms of ''somatostatin'' are as follows: * growth hormone–inhibiting hormone (GHIH) * growth hormone release–inhibiting hormone (GHRIH) * somatotropin release–inhibiting factor (SRIF) * somatotropin release–inhibiting hormone (SRIH) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Somatostatin」の詳細全文を読む スポンサード リンク
|